StoneX Group’s Intercure INCR Stock Holding History

StoneX Group’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,541	Closed	-$81.2K	–	1146
2025 Q3	$81.2K	Buy	+49,541	New	+$77.1K	﹤0.01%	859

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return

StoneX Group's INCR Position: Q4 2025 in Review

StoneX Group sold out of Intercure (INCR) in Q4 2025, closing a stake of 49,541 shares — an estimated $81.2K sold.

StoneX Group first reported a position in INCR in Q3 2025 and held it in 1 quarter. The position peaked at $81.2K in Q3 2025. 19 funds tracked by Wall St. Rank hold INCR as of Q4 2025.

StoneX Group reported no remaining Intercure position as of Q4 2025 after selling out during the quarter.
StoneX Group sold 49,541 Intercure shares in Q4 2025, an estimated $81.2K.
StoneX Group first reported a position in Intercure in Q3 2025 and held it in 1 quarter.
StoneX Group's Intercure position peaked at $81.2K in Q3 2025.
19 funds tracked by Wall St. Rank held Intercure as of Q4 2025.

Based on StoneX Group's 13F filing for Q4 2025, filed 12 Feb 2026.